The FDA approved tavapadon (Juvmo) tablets for the treatment of adults with Parkinson disease (PD). The company described the ...

Tozorakimab (MEDI3506) met its primary and key secondary end points in the Phase 3 OBERON ( NCT05166889) and TITANIA ( ...

Lean-mass changes should be interpreted with performance endpoints, including handgrip strength, rather than isolated ...

Documentation limitations were the most frequently identified theme and included the absence of structured menopause-specific ...

Vaccination and natural infection both train the immune system, but only one route carries the added risk of long COVID and ...

Enrolled participants were predominantly vertically infected, long-term suppressed adolescents; dosing transitioned from initial injections to maintenance every 8 weeks, with median follow-up ...

Heading into the 2026 respiratory virus season, pharmacists have historically been tasked with matching the right product with the right symptom for the right patient, rather than letting marketing ...

Children and adolescents with type 1 diabetes (T1D) who begin continuous glucose monitoring (CGM) within the first month of ...

If signed into law, the Main Street Pharmacy Access Act will not arrive as the sweeping, all-encompassing provider-status bill some in the pharmacy profession had envisioned. Experts explain, however, ...

COVID-19 vaccine resistance has shifted from acute ideological opposition toward broader apathy, a trend now spilling into ...

National claims data (>104 million adults) showed higher unadjusted GLP-1 use in SMI, but adjustment for indications and ...

Menopausal hormone therapy (MHT) initiated during perimenopause or early postmenopause was associated with a 22% reduction in cardiovascular disease (CVD) risk among women with va ...